Literature DB >> 25695106

Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.

Nirupama Putcha1, Meilan K Han2, Carlos H Martinez2, Marilyn G Foreman3, Antonio R Anzueto4, Richard Casaburi5, Michael H Cho6, Nicola A Hanania7, Craig P Hersh6, Gregory L Kinney8, Barry J Make9, Robert M Steiner10, Sharon M Lutz8, Byron M Thomashow11, Andre A Williams12, Surya P Bhatt13, Terri H Beaty14, Russell P Bowler9, Joe W Ramsdell15, Jeffrey L Curtis2, Douglas Everett12, John E Hokanson8, David A Lynch16, E Rand Sutherland9, Edwin K Silverman6, James D Crapo9, Robert A Wise1, Elizabeth A Regan17, Nadia N Hansel1.   

Abstract

BACKGROUND: COPD patients have a great burden of comorbidity. However, it is not well established whether this is due to shared risk factors such as smoking, if they impact patients exercise capacity and quality of life, or whether there are racial disparities in their impact on COPD.
METHODS: We analyzed data from 10,192 current and ex-smokers with (cases) and without COPD (controls) from the COPDGene® cohort to establish risk for COPD comorbidities adjusted for pertinent covariates. In adjusted models, we examined comorbidities prevalence and impact in African-Americans (AA) and Non-Hispanic Whites (NHW).
RESULTS: Comorbidities are more common in COPD compared to those with normal spirometry (controls), and the risk persists after adjustments for covariates including pack-years smoked. After adjustment for confounders, eight conditions were independently associated with worse exercise capacity, quality of life and dyspnea. There were racial disparities in the impact of comorbidities on exercise capacity, dyspnea and quality of life, presence of osteoarthritis and gastroesophageal reflux disease having a greater negative impact on all three outcomes in AAs than NHWs (p<0.05 for all interaction terms).
CONCLUSIONS: Individuals with COPD have a higher risk for comorbidities than controls, an important finding shown for the first time comprehensively after accounting for confounders. Individual comorbidities are associated with worse exercise capacity, quality of life, and dyspnea, in African-Americans compared to non-Hispanic Whites.

Entities:  

Keywords:  COPD; Comorbidities; Race

Year:  2014        PMID: 25695106      PMCID: PMC4329763          DOI: 10.15326/jcopdf.1.1.2014.0112

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  59 in total

1.  Self-report as an indicator of incident disease.

Authors:  Tuula Oksanen; Mika Kivimäki; Jaana Pentti; Marianna Virtanen; Timo Klaukka; Jussi Vahtera
Journal:  Ann Epidemiol       Date:  2010-07       Impact factor: 3.797

2.  The St George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock
Journal:  Respir Med       Date:  1991-09       Impact factor: 3.415

3.  Genetic epidemiology of COPD (COPDGene) study design.

Authors:  Elizabeth A Regan; John E Hokanson; James R Murphy; Barry Make; David A Lynch; Terri H Beaty; Douglas Curran-Everett; Edwin K Silverman; James D Crapo
Journal:  COPD       Date:  2010-02       Impact factor: 2.409

4.  Obesity and COPD: associated symptoms, health-related quality of life, and medication use.

Authors:  Laura M Cecere; Alyson J Littman; Christopher G Slatore; Edmunds M Udris; Chris L Bryson; Edward J Boyko; David J Pierson; David H Au
Journal:  COPD       Date:  2011-08-02       Impact factor: 2.409

5.  Do health interview surveys yield reliable data on chronic illness among older respondents?

Authors:  M Beckett; M Weinstein; N Goldman; L Yu-Hsuan
Journal:  Am J Epidemiol       Date:  2000-02-01       Impact factor: 4.897

6.  Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease.

Authors:  R Antonelli Incalzi; L Fuso; M De Rosa; F Forastiere; E Rapiti; B Nardecchia; R Pistelli
Journal:  Eur Respir J       Date:  1997-12       Impact factor: 16.671

7.  Increased gastro-oesophageal reflux disease in patients with severe COPD.

Authors:  C Casanova; J S Baudet; M del Valle Velasco; J M Martin; A Aguirre-Jaime; J P de Torres; J Pablo de Torres; B R Celli
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

8.  The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD.

Authors:  K Ramachandran; C McCusker; M Connors; R Zuwallack; B Lahiri
Journal:  Chron Respir Dis       Date:  2008       Impact factor: 2.444

9.  The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.

Authors:  Kerry Schnell; Carlos O Weiss; Todd Lee; Jerry A Krishnan; Bruce Leff; Jennifer L Wolff; Cynthia Boyd
Journal:  BMC Pulm Med       Date:  2012-07-09       Impact factor: 3.317

10.  Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality.

Authors:  Pierre-Régis Burgel; Jean-Louis Paillasseur; Bernard Peene; Daniel Dusser; Nicolas Roche; Johan Coolen; Thierry Troosters; Marc Decramer; Wim Janssens
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

View more
  20 in total

1.  Chronic Obstructive Pulmonary Disease in America's Black Population.

Authors:  Chinedu O Ejike; Mark T Dransfield; Nadia N Hansel; Nirupama Putcha; Sarath Raju; Carlos H Martinez; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2019-08-15       Impact factor: 21.405

Review 2.  Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.

Authors:  Diego J Maselli; Surya P Bhatt; Antonio Anzueto; Russell P Bowler; Dawn L DeMeo; Alejandro A Diaz; Mark T Dransfield; Ashraf Fawzy; Marilyn G Foreman; Nicola A Hanania; Craig P Hersh; Victor Kim; Gregory L Kinney; Nirupama Putcha; Emily S Wan; J Michael Wells; Gloria E Westney; Kendra A Young; Edwin K Silverman; MeiLan K Han; Barry J Make
Journal:  Chest       Date:  2019-05-30       Impact factor: 9.410

3.  Trends in 30-day readmission rates after COPD hospitalization, 2006-2012.

Authors:  Tadahiro Goto; Mohammad Kamal Faridi; Koichiro Gibo; Sengwee Toh; Nicola A Hanania; Carlos A Camargo; Kohei Hasegawa
Journal:  Respir Med       Date:  2017-07-26       Impact factor: 3.415

Review 4.  Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.

Authors:  Michael Schivo; Timothy E Albertson; Angela Haczku; Nicholas J Kenyon; Amir A Zeki; Brooks T Kuhn; Samuel Louie; Mark V Avdalovic
Journal:  J Investig Med       Date:  2017-03-03       Impact factor: 2.895

5.  Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.

Authors:  Carlos H Martinez; Susan Murray; R Graham Barr; Eugene Bleecker; Russell P Bowler; Stephanie A Christenson; Alejandro P Comellas; Christopher B Cooper; David Couper; Gerard J Criner; Jeffrey L Curtis; Mark T Dransfield; Nadia N Hansel; Eric A Hoffman; Richard E Kanner; Eric Kleerup; Jerry A Krishnan; Stephen C Lazarus; Nancy K Leidy; Wanda O'Neal; Fernando J Martinez; Robert Paine; Stephen I Rennard; Donald P Tashkin; Prescott G Woodruff; MeiLan K Han
Journal:  Ann Am Thorac Soc       Date:  2017-05

6.  Influence of comorbidities in long-term survival of chronic obstructive pulmonary disease patients.

Authors:  Selma Aydogan Eroglu; Hakan Gunen; Halil Ibrahim Yakar; Ethem Yildiz; Murat Kavas; Dildar Duman
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

7.  Race and Sex Differences in Mortality in Individuals with Chronic Obstructive Pulmonary Disease.

Authors:  Jamuna K Krishnan; Mangala Rajan; Samprit Banerjee; Sonal G Mallya; MeiLan K Han; David M Mannino; Fernando J Martinez; Monika M Safford
Journal:  Ann Am Thorac Soc       Date:  2022-10

8.  Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD.

Authors:  Allison A Lambert; Nirupama Putcha; M Bradley Drummond; Aladin M Boriek; Nicola A Hanania; Victor Kim; Gregory L Kinney; Merry-Lynn N McDonald; Emily P Brigham; Robert A Wise; Meredith C McCormack; Nadia N Hansel
Journal:  Chest       Date:  2016-08-25       Impact factor: 9.410

Review 9.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Authors:  Nirupama Putcha; M Bradley Drummond; Robert A Wise; Nadia N Hansel
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

10.  Associations of Multimorbid Medical Conditions and Health-Related Quality of Life Among Older African American Men.

Authors:  Olivio J Clay; Martinique Perkins; Gail Wallace; Michael Crowe; Patricia Sawyer; Cynthia J Brown
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2018-01-11       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.